Clinical Decision Support Systems Market by Component (Services, Software), Delivery Mode, Product Type (Integrated, Standalone), Model (Knowledge-Based), Type (Therapeutic, Diagnostic), User Interactivity (Active, Passive), Application - Forecasts to 2021
The clinical decision support systems market is expected to reach USD 1,519.2 million by 2021 from USD 856.3 million in 2016, at a CAGR of 12.2% during the forecast period from 2016 to 2021. The government support and initiatives to drive adoption of HCIT solutions in healthcare, rising incidence of medication errors, rising prominence and usage of Big Data and m-Health tools, growing adoption of cloud computing in healthcare and prevalence of chronic diseases are some of the factors driving the growth of the clinical decision support systems market.
Clinical decision support systems are gaining popularity across the globe; the use of health information technologies and online resources in healthcare boosts clinical decision making by providing access to a wealth of information presented in a timely manner to make the best possible patient-specific decisions as per circumstances. These systems also reduce commission and omission errors and enhance the quality of care. The benefits offered by clinical decision support systems is driving stakeholders in the healthcare system including key industry players, healthcare providers and governments to take measures to integrate these systems into clinical workflows. However, reluctance amongst traditional healthcare providers to adopt the solutions, requirement of high investments for supporting IT infrastructure, data security concerns related to cloud-based systems and lack of interoperability are some of the factors expected to restrain the growth of this market.
On the other hand, emerging markets for healthcare IT in regions such as Asia-Pacific, Middle East, Latin America and Africa, and technological advancements in HCIT solutions offer growth opportunities for players in the market.
The clinical decision support systems market is expected to be challenged by the lack of skilled IT professionals in the healthcare sector.
Geographically, North America is expected to account for the largest share of the global clinical decision support systems market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American market is attributed to favorable initiatives and regulatory mandates, enterprises by key industry players, and rising incidence of medication errors in U.S.; and rising personalized medicine initiatives and prevalence of chronic diseases in Canada.
In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the clinical decision support systems market place.
Research Coverage:
The report segments the global clinical decision support systems market on the basis of component, delivery mode, product, type, model, user interactivity, application, and region, with analysis and forecasts to 2021.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
Clinical decision support systems are gaining popularity across the globe; the use of health information technologies and online resources in healthcare boosts clinical decision making by providing access to a wealth of information presented in a timely manner to make the best possible patient-specific decisions as per circumstances. These systems also reduce commission and omission errors and enhance the quality of care. The benefits offered by clinical decision support systems is driving stakeholders in the healthcare system including key industry players, healthcare providers and governments to take measures to integrate these systems into clinical workflows. However, reluctance amongst traditional healthcare providers to adopt the solutions, requirement of high investments for supporting IT infrastructure, data security concerns related to cloud-based systems and lack of interoperability are some of the factors expected to restrain the growth of this market.
On the other hand, emerging markets for healthcare IT in regions such as Asia-Pacific, Middle East, Latin America and Africa, and technological advancements in HCIT solutions offer growth opportunities for players in the market.
The clinical decision support systems market is expected to be challenged by the lack of skilled IT professionals in the healthcare sector.
Geographically, North America is expected to account for the largest share of the global clinical decision support systems market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American market is attributed to favorable initiatives and regulatory mandates, enterprises by key industry players, and rising incidence of medication errors in U.S.; and rising personalized medicine initiatives and prevalence of chronic diseases in Canada.
In-depth interviews were conducted with CEOs, Sales and Marketing Directors, other innovation and technology directors, and executives from various key organizations operating in the clinical decision support systems market place.
- By Company Type: Tier 1: 50%, Tier 2: 35%, Tier 3: 15%
- By Designation: Director Level: 29%, C-Level: 39%, Others: 32%
- By Region: North America: 32%, Europe: 24%, APAC: 26%, ROW: 18%
Research Coverage:
The report segments the global clinical decision support systems market on the basis of component, delivery mode, product, type, model, user interactivity, application, and region, with analysis and forecasts to 2021.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the solutions offered by top players in the clinical decision support systems market. The report analyzes the clinical decision support systems market, by component, delivery mode, product, type, model, user interactivity, and application
- Product Development/Innovation: Detailed insights on research and development activities and new product launches in the clinical decision support systems market
- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the clinical decision support systems market across regions
- Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the clinical decision support systems market
- Competitive Assessment: In-depth assessment of strategies, products, and distribution networks of the leading players in the clinical decision support systems market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH METHODOLOGY STEPS
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
2.2.2.1 Key industry insights
2.2.2.2 Key data from primary sources
2.2.2.3 Key insights from primary sources
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.4 MARKET DATA VALIDATION AND TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CONCLUSION
4 PREMIUM INSIGHTS
4.1 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW
4.2 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL (2016 VS. 2021)
4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY USER INTERACTIVITY (2016 VS. 2021)
4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION (2016 VS. 2021)
4.5 GEOGRAPHIC SNAPSHOT: CLINICAL DECISION SUPPORT SYSTEMS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Government support and initiatives
5.2.1.2 High prevalence of chronic diseases
5.2.1.3 Growing incidence of medication errors
5.2.1.4 Rising usage of Big Data and m-Health tools
5.2.1.5 Growing adoption of cloud computing in healthcare
5.2.2 MARKET RESTRAINTS
5.2.2.1 Reluctance among traditional providers to adopt CDSS
5.2.2.2 Requirement of high investments for IT infrastructure
5.2.2.3 Data security concerns related to cloud-based CDSS
5.2.2.4 Lack of interoperability
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Emerging markets for healthcare IT
5.2.3.2 Technological advancements in healthcare IT solutions
5.2.4 MARKET CHALLENGE
5.2.4.1 Lack of skilled IT professionals in the healthcare industry
6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT
6.1 INTRODUCTION
6.2 SERVICES
6.3 SOFTWARE
6.4 HARDWARE
7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE
7.1 INTRODUCTION
7.2 WEB-BASED CLINICAL DECISION SUPPORT SYSTEMS
7.3 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS
7.4 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS
8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT
8.1 INTRODUCTION
8.2 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS
8.3 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS
9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE
9.1 INTRODUCTION
9.2 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS
9.3 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS
10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL
10.1 INTRODUCTION
10.2 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS
10.3 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS
11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY USER INTERACTIVITY
11.1 INTRODUCTION
11.2 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS
11.3 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS
12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS
12.3 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS
13 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION
13.1 INTRODUCTION
13.2 NORTH AMERICA
13.2.1 U.S.
13.2.1.1 Favorable initiatives boosting the adoption of CDSS
13.2.1.2 Growing healthcare spending in U.S.
13.2.1.3 Regulatory mandates in the U.S.
13.2.1.4 High medical error incidence
13.2.1.5 Initiatives by industry players to advance clinical diagnosis
13.2.2 CANADA
13.2.2.1 Growing prevalence of chronic diseases in Canada
13.2.2.2 Initiatives by Canada Health Infoway
13.2.2.3 Rising personalized medicine initiatives in Canada
13.3 EUROPE
13.3.1 GERMANY
13.3.1.1 Rising demand for advanced solutions and efficient healthcare delivery in Germany
13.3.1.2 Presence of a strong insurance system, government initiatives to modernize the healthcare system in Germany
13.3.2 U.K.
13.3.2.1 Government Initiatives in the U.K.
13.3.3 FRANCE
13.3.3.1 Challenges in the French healthcare system
13.3.4 ROE
13.4 ASIA-PACIFIC
13.4.1 INVESTMENTS AND REFORMS TO MODERNIZE CHINA’S HEALTHCARE INFRASTRUCTURE
13.4.2 GROWING FOCUS ON HCIT IN CHINA
13.4.3 MEASURES TO BOOST HEALTHCARE DELIVERY IN JAPAN
13.4.4 RAPIDLY GROWING INDIAN HEALTHCARE INDUSTRY
13.4.5 IMPLEMENTATION OF HCIT PROGRAMS IN AUSTRALIA
13.4.6 GOVERNMENT INITIATIVES TO BOOST HCIT IN SINGAPORE
13.4.7 GROWTH IN MEDICAL TOURISM
13.5 ROW
13.5.1 FAVORABLE ENVIRONMENT FOR THE GROWTH OF THE CDSS IN AFRICA
13.5.2 RISING AWARENESS REGARDING HCIT SOLUTIONS IN BRAZIL
13.5.3 MODERNIZATION OF HEALTHCARE SYSTEMS IN THE MIDDLE EAST
14 COMPETITIVE LANDSCAPE
14.1 OVERVIEW
14.2 COMPARATIVE ASSESSMENT OF KEY PLAYERS IN CDSS MARKET (2013-2016)
14.3 COMPETITIVE SITUATION AND TRENDS
14.3.1 PRODUCT DEPLOYMENT
14.3.2 PRODUCT LAUNCHES, ENHANCEMENTS, AND INTEGRATION
14.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
14.3.4 ACQUISITION
14.3.5 OTHERS
15 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
15.1 INTRODUCTION
15.2 CERNER CORPORATION
15.3 MCKESSON CORPORATION
15.4 EPIC SYSTEMS CORPORATION
15.5 MEDITECH
15.6 PHILIPS HEALTHCARE
15.7 WOLTERS KLUWER HEALTH
15.8 ZYNX HEALTH
15.9 ELSEVIER B.V. (A DIVISION OF THE RELX GROUP)
15.10 IBM CORPORATION
15.11 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 OTHER DEVELOPMENTS
16.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
16.5 AVAILABLE CUSTOMIZATIONS
16.6 RELATED REPORTS
16.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH METHODOLOGY STEPS
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
2.2.2.1 Key industry insights
2.2.2.2 Key data from primary sources
2.2.2.3 Key insights from primary sources
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.4 MARKET DATA VALIDATION AND TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CONCLUSION
4 PREMIUM INSIGHTS
4.1 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW
4.2 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL (2016 VS. 2021)
4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY USER INTERACTIVITY (2016 VS. 2021)
4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION (2016 VS. 2021)
4.5 GEOGRAPHIC SNAPSHOT: CLINICAL DECISION SUPPORT SYSTEMS MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 MARKET DRIVERS
5.2.1.1 Government support and initiatives
5.2.1.2 High prevalence of chronic diseases
5.2.1.3 Growing incidence of medication errors
5.2.1.4 Rising usage of Big Data and m-Health tools
5.2.1.5 Growing adoption of cloud computing in healthcare
5.2.2 MARKET RESTRAINTS
5.2.2.1 Reluctance among traditional providers to adopt CDSS
5.2.2.2 Requirement of high investments for IT infrastructure
5.2.2.3 Data security concerns related to cloud-based CDSS
5.2.2.4 Lack of interoperability
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 Emerging markets for healthcare IT
5.2.3.2 Technological advancements in healthcare IT solutions
5.2.4 MARKET CHALLENGE
5.2.4.1 Lack of skilled IT professionals in the healthcare industry
6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT
6.1 INTRODUCTION
6.2 SERVICES
6.3 SOFTWARE
6.4 HARDWARE
7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE
7.1 INTRODUCTION
7.2 WEB-BASED CLINICAL DECISION SUPPORT SYSTEMS
7.3 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS
7.4 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS
8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT
8.1 INTRODUCTION
8.2 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS
8.3 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS
9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE
9.1 INTRODUCTION
9.2 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS
9.3 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS
10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL
10.1 INTRODUCTION
10.2 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS
10.3 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS
11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY USER INTERACTIVITY
11.1 INTRODUCTION
11.2 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS
11.3 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS
12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION
12.1 INTRODUCTION
12.2 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS
12.3 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS
13 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION
13.1 INTRODUCTION
13.2 NORTH AMERICA
13.2.1 U.S.
13.2.1.1 Favorable initiatives boosting the adoption of CDSS
13.2.1.2 Growing healthcare spending in U.S.
13.2.1.3 Regulatory mandates in the U.S.
13.2.1.4 High medical error incidence
13.2.1.5 Initiatives by industry players to advance clinical diagnosis
13.2.2 CANADA
13.2.2.1 Growing prevalence of chronic diseases in Canada
13.2.2.2 Initiatives by Canada Health Infoway
13.2.2.3 Rising personalized medicine initiatives in Canada
13.3 EUROPE
13.3.1 GERMANY
13.3.1.1 Rising demand for advanced solutions and efficient healthcare delivery in Germany
13.3.1.2 Presence of a strong insurance system, government initiatives to modernize the healthcare system in Germany
13.3.2 U.K.
13.3.2.1 Government Initiatives in the U.K.
13.3.3 FRANCE
13.3.3.1 Challenges in the French healthcare system
13.3.4 ROE
13.4 ASIA-PACIFIC
13.4.1 INVESTMENTS AND REFORMS TO MODERNIZE CHINA’S HEALTHCARE INFRASTRUCTURE
13.4.2 GROWING FOCUS ON HCIT IN CHINA
13.4.3 MEASURES TO BOOST HEALTHCARE DELIVERY IN JAPAN
13.4.4 RAPIDLY GROWING INDIAN HEALTHCARE INDUSTRY
13.4.5 IMPLEMENTATION OF HCIT PROGRAMS IN AUSTRALIA
13.4.6 GOVERNMENT INITIATIVES TO BOOST HCIT IN SINGAPORE
13.4.7 GROWTH IN MEDICAL TOURISM
13.5 ROW
13.5.1 FAVORABLE ENVIRONMENT FOR THE GROWTH OF THE CDSS IN AFRICA
13.5.2 RISING AWARENESS REGARDING HCIT SOLUTIONS IN BRAZIL
13.5.3 MODERNIZATION OF HEALTHCARE SYSTEMS IN THE MIDDLE EAST
14 COMPETITIVE LANDSCAPE
14.1 OVERVIEW
14.2 COMPARATIVE ASSESSMENT OF KEY PLAYERS IN CDSS MARKET (2013-2016)
14.3 COMPETITIVE SITUATION AND TRENDS
14.3.1 PRODUCT DEPLOYMENT
14.3.2 PRODUCT LAUNCHES, ENHANCEMENTS, AND INTEGRATION
14.3.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
14.3.4 ACQUISITION
14.3.5 OTHERS
15 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
15.1 INTRODUCTION
15.2 CERNER CORPORATION
15.3 MCKESSON CORPORATION
15.4 EPIC SYSTEMS CORPORATION
15.5 MEDITECH
15.6 PHILIPS HEALTHCARE
15.7 WOLTERS KLUWER HEALTH
15.8 ZYNX HEALTH
15.9 ELSEVIER B.V. (A DIVISION OF THE RELX GROUP)
15.10 IBM CORPORATION
15.11 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 OTHER DEVELOPMENTS
16.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
16.5 AVAILABLE CUSTOMIZATIONS
16.6 RELATED REPORTS
16.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 RISING INCIDENCE OF MEDICATION ERRORS IS PROPELLING THE GROWTH OF THE GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET
Table 2 RELUCTANCE AMONG TRADITIONAL PROVIDERS TO ADOPT CDSS ACTS AS A KEY RESTRAINT TO MARKET GROWTH
Table 3 EMERGING MARKETS OFFER LUCRATIVE GROWTH POTENTIAL
Table 4 LACK OF SKILLED IT PROFESSIONALS IS A MAJOR CHALLENGE FOR THE GROWTH OF THE CDSS MARKET
Table 5 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2014–2021 (USD MILLION)
Table 6 CLINICAL DECISION SUPPORT SERVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 7 CLINICAL DECISION SUPPORT SOFTWARE MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 8 CLINICAL DECISION SUPPORT HARDWARE MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 9 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 10 WEB-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 11 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 12 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 13 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2014–2021 (USD MILLION)
Table 14 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 15 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 16 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2014–2021 (USD MILLION)
Table 17 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 18 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 20 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 21 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 22 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY, 2014–2021 (USD MILLION)
Table 23 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 24 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 25 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2014–2021 (USD MILLION)
Table 26 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 27 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 29 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 30 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 31 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 32 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 33 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 34 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 35 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 36 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 37 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 38 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 39 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 40 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 41 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 42 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY INTERACTIVITY, 2014–2021 (USD MILLION)
Table 43 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 44 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 45 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 46 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 47 CANADA.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 48 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 49 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY INTERACTIVITY, 2014–2021 (USD MILLION)
Table 50 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 51 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 52 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 53 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 54 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 55 EUROPE.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 56 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 57 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 58 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 59 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 60 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 61 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 62 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 63 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 64 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 65 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 66 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 67 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 68 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 69 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 70 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 71 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 72 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 73 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 74 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 75 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 76 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 77 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 78 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 79 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 80 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 81 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 82 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 83 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 84 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 85 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 86 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 87 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 88 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 89 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 90 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 91 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 92 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 93 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 94 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 95 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 96 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 97 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 98 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 99 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 100 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 101 PRODUCT DEPLOYMENTS, 2013–2016
Table 102 PRODUCT LAUNCHES, ENHANCEMENTS, AND INTEGRATION, 2013–2016
Table 103 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 2013–2016
Table 104 ACQUISITIONS, 2013–2016
Table 1 RISING INCIDENCE OF MEDICATION ERRORS IS PROPELLING THE GROWTH OF THE GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET
Table 2 RELUCTANCE AMONG TRADITIONAL PROVIDERS TO ADOPT CDSS ACTS AS A KEY RESTRAINT TO MARKET GROWTH
Table 3 EMERGING MARKETS OFFER LUCRATIVE GROWTH POTENTIAL
Table 4 LACK OF SKILLED IT PROFESSIONALS IS A MAJOR CHALLENGE FOR THE GROWTH OF THE CDSS MARKET
Table 5 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2014–2021 (USD MILLION)
Table 6 CLINICAL DECISION SUPPORT SERVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 7 CLINICAL DECISION SUPPORT SOFTWARE MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 8 CLINICAL DECISION SUPPORT HARDWARE MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 9 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 10 WEB-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 11 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 12 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 13 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2014–2021 (USD MILLION)
Table 14 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 15 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 16 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2014–2021 (USD MILLION)
Table 17 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 18 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 19 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 20 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 21 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 22 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY, 2014–2021 (USD MILLION)
Table 23 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 24 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 25 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2014–2021 (USD MILLION)
Table 26 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 27 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 29 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 30 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 31 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 32 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 33 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 34 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 35 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 36 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 37 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 38 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 39 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 40 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 41 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 42 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY INTERACTIVITY, 2014–2021 (USD MILLION)
Table 43 U.S.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 44 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 45 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 46 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 47 CANADA.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 48 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 49 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY INTERACTIVITY, 2014–2021 (USD MILLION)
Table 50 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 51 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 52 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 53 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 54 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 55 EUROPE.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 56 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 57 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 58 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 59 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 60 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 61 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 62 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 63 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 64 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 65 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 66 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 67 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 68 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 69 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 70 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 71 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 72 U.K.: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 73 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 74 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 75 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 76 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 77 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 78 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 79 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 80 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 81 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 82 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 83 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 84 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 85 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 86 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 87 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 88 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 89 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 90 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 91 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 92 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 93 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 94 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY COMPONENT, 2014–2021 (USD MILLION)
Table 95 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY DELIVERY MODE, 2014–2021 (USD MILLION)
Table 96 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 97 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 98 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY MODEL, 2014–2021 (USD MILLION)
Table 99 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY USER INTERACTIVITY, 2014–2021 (USD MILLION)
Table 100 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION)
Table 101 PRODUCT DEPLOYMENTS, 2013–2016
Table 102 PRODUCT LAUNCHES, ENHANCEMENTS, AND INTEGRATION, 2013–2016
Table 103 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 2013–2016
Table 104 ACQUISITIONS, 2013–2016
Clinical decision support systems (CDSS) not only retrieve stored data and analyze historical and current data but also have the capability to advise patients at the point of care. The global CDSS market is estimated to reach $xx million by 2018 at a CAGR of xx% during the forecast period (2013-2018).
The CDSS market is segmented by product, model, application, delivery mode, component, and provider entity capacity. Based on products, the CDSS market is further segmented into integrated and standalone CDSS solutions. Integrated solutions are mainly available in three different combinations, namely, EHR-CDSS, EHR-CDSS-CPOE, and CDSS-CPOE. Of all the combinations. EHR-CDSS-CPOE will be the fastest-growing market at a CAGR of xx% in the coming five years.
Knowledge-based models are dominant CDSS models in the market, which accounted for a share of xx%in 2013 and were valued at$xx million.
Based on applications, the CDSS market is segmented into drug allergy alerts, drug reminders, drug-drug interactions, clinical guidelines, clinical reminders, drug dosing support, and others.
Drug allergy alerts accounted for the largest share of xx% of the global CDSS market in 2013.0n the other hand, clinical reminders will witness the fastest growth at an estimated CAGR of xx% from 2013 to 2018.
The three most important delivery modes considered for the study are web-based, on-premises, and cloud computing. The cloud computing mode of delivery is expected to grow at the fastest pace of xx% in the forecast period (2013-2018). Under healthcare provider entity capacity, providers are segmented by number of beds, which ranges from less than xx beds to more than xx beds. The CDSS market for hospitals with less than 100 beds accounted for the largest share of xx% of the overall CDSS market in 2013.
Market dynamics analysis has identified that rising budgetary pressure to reduce healthcare expenditures, increasing aging population, rising incidences of various diseases due to medication errors, growing need to integrate healthcare IT solutions, improved quality of care and clinical outcomes, and conducive government initiatives are significant factors propelling the market in the forecast period. On the other hand, rising incidences of data breach and loss of confidentiality, high maintenance and service expenses, shortage of trained IT professionals, and high costs of CDSS solutions are the factors that hinder the market.
Geographic analysis reveals that North America was the largest contributor to the global clinical decision support system market and occupied a share of xx% in 2013. It will also be the fastest growing region for CDSS till 2018. The Asian countries, on the other hand, are poised to grow at moderate CAGRs of xx% from 2013 to 2018.
The key players in the market are MEDITECH (U.S.), Cerner Corporation (U.S.), Carestream Health, Inc. (U.S.), McKesson Corporation (U.S.), Athenahealth, Inc. (U.S.), Siemens Healthcare (Germany). Allscripts Healthcare Solutions. Inc. (U.S.), GE Healthcare (U.K.), Agfa Healthcare (Belgium), NextGen Healthcare Information System LLC (U.S.), Novarad Corporation (U.S.), Philips Healthcare (The Netherlands), Wolters Kluwer (U.S.). Zynx Health (U.S.). and Epic (U.S.). Of all the players, MEDITECH accounted for largest share of xx% in 2013.
